Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2613486rdf:typepubmed:Citationlld:pubmed
pubmed-article:2613486lifeskim:mentionsumls-concept:C0268382lld:lifeskim
pubmed-article:2613486lifeskim:mentionsumls-concept:C0750729lld:lifeskim
pubmed-article:2613486pubmed:issue5lld:pubmed
pubmed-article:2613486pubmed:dateCreated1990-3-12lld:pubmed
pubmed-article:2613486pubmed:abstractTextThe course of uraemia in 47 patients with renal amyloidosis has been studied. The median survival with a S-creatinine of 150 mumol/l was approximately 18 months, but 15% survived for more than 3 years. Deterioration arose often suddenly and was of unclear cause. Approximately 25% of the patients improved for a while and the reason for this temporary improvement is also unclear. The unsteady course during the uraemia period for amyloidosis patients makes prognosis calculations very much less accurate than for patients with cystic kidneys.lld:pubmed
pubmed-article:2613486pubmed:languageenglld:pubmed
pubmed-article:2613486pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2613486pubmed:citationSubsetIMlld:pubmed
pubmed-article:2613486pubmed:statusMEDLINElld:pubmed
pubmed-article:2613486pubmed:issn0301-1623lld:pubmed
pubmed-article:2613486pubmed:authorpubmed-author:LindqvistBBlld:pubmed
pubmed-article:2613486pubmed:authorpubmed-author:LundbergEElld:pubmed
pubmed-article:2613486pubmed:authorpubmed-author:AndersenSSlld:pubmed
pubmed-article:2613486pubmed:authorpubmed-author:IsacssonBBlld:pubmed
pubmed-article:2613486pubmed:issnTypePrintlld:pubmed
pubmed-article:2613486pubmed:volume21lld:pubmed
pubmed-article:2613486pubmed:ownerNLMlld:pubmed
pubmed-article:2613486pubmed:authorsCompleteYlld:pubmed
pubmed-article:2613486pubmed:pagination555-9lld:pubmed
pubmed-article:2613486pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:meshHeadingpubmed-meshheading:2613486-...lld:pubmed
pubmed-article:2613486pubmed:year1989lld:pubmed
pubmed-article:2613486pubmed:articleTitleThe course of renal amyloidosis with uraemia.lld:pubmed
pubmed-article:2613486pubmed:affiliationMedical Department, Umeå University, Sweden.lld:pubmed
pubmed-article:2613486pubmed:publicationTypeJournal Articlelld:pubmed